See What Eric Lefkofsky Is Doing To Get Cancer Patients A Lasting Solution

Cancer, Company

Cancer is one of the fastest killing agents today. It’s amazing that even children are diagnosed with cancer unlike in the past when it was just associated with the adults. Lung cancer is probably one of the cancer types spreading so fast. Genetic risks and environmental factors such as tobacco smoking are the two major causes of lung cancer today. A lot of research about lung cancer and cancer, in general, has been done. It emerges that it will take technology to deal with these dreadful conditions. Eric Lefkofsky is one of the esteemed medical technology people who look forward for a solution in this.

Eric founded Tempus, and he serves as the Chief Executive Officer. Tempus is a tech company in Chicago that deals with clinical and molecular data and research. Erick hopes the company will be the greatest research hub in the world with exceptional information on clinical and molecular aspects. The company’s main mandate is to collect useful information that would greatly help the cancer patients and physicians. Eric Lefkofsky says he intends to come with patient-proved outcomes. He also hopes to make Tempus a personalized center for cancer patients.

Tempus was founded in 2015, and it has over 200 employees now. More than $70 million has been raised in this company so far. If you were to describe Eric’s career, you would say it’s something that has span beyond entrepreneurship. Having known and seen how the cancer patients suffer, Eric has developed a strong philanthropic spirit. He says if people used their money to support scientific research centers, a lasting solution to cancer would be found. Eric has been concerned about the amount of money cancer patients use to seek health services. A person close to him developed cancer, and Eric realized that the doctor that treated the sick person didn’t have adequate technology and the right facilities to do so.

To Know More Click Here

Cancer Treatment Centers of America & NFL Team Up To Tackle Prostate Cancer Awareness

Cancer, Health Care

Cancer can be one of the most devastating diseases out there as well as one of the most common. There are many forms of cancer but one of the most deadly is prostate cancer. It is predicted that one is seven men will be diagnosed prostate cancer within their lifetimes. African American men are 70% more likely to be diagnosed with prostate cancer.

The Cancer Society of America is estimating that over 160,000 men will be diagnosed with prostate cancer within the year 2017. It is very highly recommended that men who are at a higher risk of developing prostate cancer get screened at age 40. Many men, who are either of the age to begin screening for prostate cancer or are at a high risk, tend to procrastinate getting screened which can lead to a much later discovery of the cancer. Early discovery is one of the best ways to stay ahead of the game as well as expand the effectiveness and options for treatment.

There is a great deal of stigma associated with the methods used for screening for prostate cancer but ultimately a bit of discomfort is an easy price to pay when your life could be on the line. The screenings involve a simple blood test, a PSA (Prostate-Specific Antigen) and a DRE, digital rectal exam where a doctor will insert a gloved finger into the rectum to physically examine prostate. The DRE can be uncomfortable and a bit embarrassing but here is something to consider: the physician performing the exam has likely endured the very same exam you are going through. It is a clinical procedure intended to ensure your health.

Partnering with the NFL, the Cancer Treatment Centers of America is on a Prostate Pep Talk campaign to raise awareness of prostate cancer and to encourage men to not skip out on the vital testing to catch it early.

The Cancer Treatment Centers of America was created in 1988 by Richard J. Stephenson who lost his mother to cancer. Richard felt strongly that his mother would have had a much better chance if the physicians involved had better treatment options.

The Cancer Treatment Centers of America is dedicated to providing a comprehensive treatment plan that goes beyond just the raw medicine to treat disease. CTCA goes past simply treating the disease and provides a wide range of therapies designed to help patients get the most out of their lives.

Visit More :

The Efforts Of Erick Lefkofsky Towards Incorporating Cancer Survivors In Clinical Trials

Cancer, Research

Cancer has certainly become a gnawing nightmare to the contemporary society. It stands as the leading chronic killer disease in the world today. Its prevalence, however, has not gone unnoticed, and medical researchers and scientists have buried their elite minds in search of a cure that will put a hold on this bushfire of a disease. Sadly, we are yet to be fortunate enough to develop a reliable cure. Nonetheless, this does not mean that this killer ailment is at liberty of terminating people’s lives. Preventive measures and standards have been developed and instituted with the sole purpose of slowing its dominance, and this is where Eric Lefkosky joins the battle against the threatening cancer horror.

Cancer Survivors

The United States currently records the largest number of cancer survivors in the world today. However, there have been considerable improvements evidenced in cancer treatment, for example, the expansion of cancer screening efforts, especially among the aging population. This significant milestone towards the fight against cancer has been very successful, and it is expected to heighten in the years to come. After the initial diagnosis, survivors have been known to live for an extended period of five to 10 years.

Understanding Prior Cancer

Prior cancer has been prevalent among people diagnosed with cancer. Irrespective of age, these cases are evident on all people, who unfortunately are ineligible for clinical trials. This occurs due to fear of negatively affecting the trial outcomes and treatment studies. Nonetheless, due to the growth of the population of cancer survivors, it is prudent to have an understanding of the impact and importance of prior cancer in conducting improved cancer trials.

Eric’s Contributions

Eric Lefkofsky shares in the dream of many other fighters against cancer. He is the CEO and Co-founder of Tempus, a technological company geared towards fighting this killer disease. Through his firm, he offers information to the doctors at the University of Chicago as a means to help curb the adversities of breast cancer among women. Tempus analyzes breast cancer patients data to assist cancer researchers in predicting how these patients will respond to various treatments. Through him and his firm, medics can now make more informed and personalized decisions on cancer therapies and treatments.

To Know More Click Here